Pediatrica Health Group announced the closing of a $28 million Series B funding round. The round was led by Valspring Capital, with participation from existing investor M33 Growth.
Pediatrica is a multi-site pediatric primary care organization focused on expanding access to care for families. The company was founded through its partnership with M33, which helped support its growth to 21 locations across Florida and Texas.
The new funding will be used to accelerate organic growth and strategic acquisitions. Pediatrica also plans to continue investing in clinical and operational infrastructure, technology enhancements, and value-based care capabilities.
The company said the investment will help expand access to pediatric primary care through more locations, more providers, and additional resources for families and communities. Pediatrica’s model is focused on supporting providers while delivering coordinated pediatric care for children from birth to age 18.
Valspring’s investment reflects its focus on growth-stage healthcare services companies. The firm said Pediatrica fits its thesis around healthcare companies that improve the patient and provider experience while expanding access and delivering better outcomes.
M33 Growth, Pediatrica’s founding investment partner, will continue playing an active role in the company’s strategic development. The investment firms said the new round positions Pediatrica for its next phase of expansion.
Pediatrica Health Group provides Next Generation Care for families and providers. The company supports pediatric care teams with modern technologies and delivering coordinated pediatric care for children from birth to age 18.
Valspring’s investment reflects its focus on growth-stage healthcare services companies. The firm said Pediatrica fits its thesis around healthcare companies that improve the patient and provider experience while expanding access and delivering better outcomes.
M33 Growth, Pediatrica’s founding investment partner, will continue playing an active role in the company’s strategic development. The investment firms said the new round positions resources designed to improve access, outcomes, and patient care.
KEY QUOTES:
“This investment reflects the momentum we have built and the confidence our partners have in our ability to reimagine, improve, and expand equitable access to pediatric primary care. Our partnership with M33 gave us the runway to prove our model and demonstrate what is possible when you remove barriers for providers and put families first. With their continued support, along with Valspring’s, we are positioned to carry that work further – reach more children, more communities, and connect more families to the quality pediatric primary care they deserve. This investment translates directly into expanded access – more locations, more providers, and better resources for the families and communities we are committed to serving. The work Pediatrica is doing today is laying the foundation for a healthier next generation, and in doing so, easing the burden on our healthcare system for generations to come – this investment accelerates continued, impactful change.”
Roberto Palenzuela of Pediatrica Health Group
“Pediatrica reflects our thesis that lasting change in healthcare is driven by companies that innovate on the patient and provider experience to deliver better outcomes. Roberto and his team have built something truly unique. Going beyond traditional care, their model nurtures communities and empowers providers while expanding access to high-quality, coordinated pediatric primary care for all families, including those underserved. We are proud to partner with Pediatrica and M33 to support this purpose-driven team to bring Next Generation Care to more communities.”
Yumin Choi, Managing Partner of Valspring
“From day one, we believed in Roberto’s vision for a better pediatric care experience. The growth Pediatrica has achieved is a testament to that vision and to the team’s relentless execution. We are excited to welcome Valspring as a partner and look forward to the next chapter of growth that Pediatrica is positioned to achieve.”
Gabe Ling, Founder of M33 Growth
